You are here

Sanofi, Regeneron expand testing of potential coronavirus treatment

file79w0geaicsnk6y4xkpo.jpg
Sanofi and Regeneron Pharmaceuticals Inc have expanded a clinical trial of their rheumatoid arthritis drug Kevzara as a coronavirus treatment to patients outside the United States.

[BENGALURU] Sanofi and Regeneron Pharmaceuticals Inc have expanded a clinical trial of their rheumatoid arthritis drug Kevzara as a coronavirus treatment to patients outside the United States.

The companies said enrolments for the mid-to-late stage trial of Kevzara, an immune-system...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes